Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsNASALGeneric

DEXACORT

DEXAMETHASONE SODIUM PHOSPHATE

Standard Dose
EQ 0.1MG PHOSPHATE/INH
Max Dose
Refer to approved labeling
Primary Use
Marketing status: Discontinued
Summary

Approval overview DEXACORT is listed in Drugs@FDA under application 014242 (NDA).

Marketing status: Discontinued Active ingredient DEXAMETHASONE SODIUM PHOSPHATE Form and strength AEROSOL;NASAL - EQ 0.1MG PHOSPHATE/INH Sponsor UCB INC Submission history Latest submission status date: 2007-12-07 00:00:00.

Structured Monograph

Clinical summary

Approval overview DEXACORT is listed in Drugs@FDA under application 014242 (NDA). Marketing status: Discontinued Active ingredient DEXAMETHASONE SODIUM PHOSPHATE Form and strength AEROSOL;NASAL - EQ 0.1MG PHOSPHATE/INH Sponsor UCB INC Submission history Latest submission status date: 2007-12-07 00:00:00. Submission type: SUPPL.

Monitoring

  • • Marketing status: Discontinued

Interaction Notes

  • No interaction notes stored yet.
DEXACORT (DEXAMETHASONE SODIUM PHOSPHATE) | Drug Monograph | MedicHelpline